Literature DB >> 21909967

Occurrence and removal of lidocaine, tramadol, venlafaxine, and their metabolites in German wastewater treatment plants.

Paola C Rúa-Gómez1, Wilhelm Püttmann.   

Abstract

PURPOSE: Some of the pharmaceuticals that are not extensively investigated in the aquatic environment are the anesthetic lidocaine (LDC), the analgesic tramadol (TRA), and the antidepressant venlafaxine (VEN). LDC metabolizes to 2,6-xylidine (2,6-DMA) and monoethylglycinexylidine (MEGX), TRA to O-desmethyltramadol (ODT), and VEN to O-desmethylvenlafaxine (ODV). Within this study, the distribution and behavior of these compounds in German wastewater treatment plants (WWTPs) were investigated.
METHODS: Samples of influents and effluents from WWTPs in Hesse, Germany were collected between January and September 2010. Analytes were extracted from wastewater samples by solid-phase extraction and from solid samples by sonication. Extracts were measured using gas chromatography/mass spectrometry.
RESULTS: LDC, TRA, VEN, ODT, and ODV were detected in all analyzed influent and effluent samples. 2,6-DMA could not be identified. MEGX was not detected. TRA and ODV were present in untreated wastewater at the highest concentrations (max, 1,129 (TRA) and 3,302 ng L⁻¹ (ODV)), while the concentrations of LDC and VEN were all significantly lower (mean, 135 (LDC) and 116 ng L⁻¹ (VEN)). All of the analytes were only partially removed in the WWTPs. The mean ratios between the concentrations of the metabolites and their respective parent compounds in influents were 4.7 (ODV/VEN) and 0.7 (ODT/TRA). These values remain approximately constant comparing influents and effluents.
CONCLUSIONS: LDC, TRA, VEN, ODT, and ODV are only partially removed from sewage water by WWTPs and thus are continuously discharged in respective recipient rivers. A further transformation of TRA and VEN into the known metabolites during treatment in the WWTPs is not observed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909967     DOI: 10.1007/s11356-011-0614-1

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  21 in total

1.  Occurrence of selected pharmaceuticals and caffeine in sewage treatment plants and receiving rivers in Beijing, China.

Authors:  Haidong Zhou; Chunying Wu; Xia Huang; Mijun Gao; Xianghua Wen; Hiroshi Tsuno; Hiroaki Tanaka
Journal:  Water Environ Res       Date:  2010-11       Impact factor: 1.946

2.  Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the ebro river basin (northeast Spain).

Authors:  Meritxell Gros; Mira Petrović; Damià Barceló
Journal:  Environ Toxicol Chem       Date:  2007-08       Impact factor: 3.742

3.  Determination of basic antidepressants and their N-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography-tandem mass spectrometry.

Authors:  A Lajeunesse; C Gagnon; S Sauvé
Journal:  Anal Chem       Date:  2008-06-14       Impact factor: 6.986

4.  Pollution by psychoactive pharmaceuticals in the Rivers of Madrid metropolitan area (Spain).

Authors:  Silvia González Alonso; Myriam Catalá; Raúl Romo Maroto; José Luis Rodríguez Gil; Angel Gil de Miguel; Yolanda Valcárcel
Journal:  Environ Int       Date:  2009-12-22       Impact factor: 9.621

5.  Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed.

Authors:  Chris D Metcalfe; Shaogang Chu; Colin Judt; Hongxia Li; Ken D Oakes; Mark R Servos; David M Andrews
Journal:  Environ Toxicol Chem       Date:  2010-01       Impact factor: 3.742

6.  Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue.

Authors:  Melissa M Schultz; Edward T Furlong; Dana W Kolpin; Stephen L Werner; Heiko L Schoenfuss; Larry B Barber; Vicki S Blazer; David O Norris; Alan M Vajda
Journal:  Environ Sci Technol       Date:  2010-03-15       Impact factor: 9.028

7.  Quantification of three lidocaine metabolites and their conjugates.

Authors:  Y K Tam; J Ke; R T Coutts; D G Wyse; M R Gray
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

8.  The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK.

Authors:  Barbara Kasprzyk-Hordern; Richard M Dinsdale; Alan J Guwy
Journal:  Water Res       Date:  2008-05-10       Impact factor: 11.236

9.  Toxicity classification and evaluation of four pharmaceuticals classes: antibiotics, antineoplastics, cardiovascular, and sex hormones.

Authors:  Hans Sanderson; Richard A Brain; David J Johnson; Christian J Wilson; Keith R Solomon
Journal:  Toxicology       Date:  2004-10-15       Impact factor: 4.221

Review 10.  Pharmaceuticals and personal care products in the environment: agents of subtle change?

Authors:  C G Daughton; T A Ternes
Journal:  Environ Health Perspect       Date:  1999-12       Impact factor: 9.031

View more
  10 in total

Review 1.  New trends in the analytical determination of emerging contaminants and their transformation products in environmental waters.

Authors:  Ana Agüera; María Jesús Martínez Bueno; Amadeo R Fernández-Alba
Journal:  Environ Sci Pollut Res Int       Date:  2013-03-01       Impact factor: 4.223

2.  Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant.

Authors:  R Salgado; R Marques; J P Noronha; G Carvalho; A Oehmen; M A M Reis
Journal:  Environ Sci Pollut Res Int       Date:  2011-12-30       Impact factor: 4.223

3.  Wastewater analysis: the mean of the monitoring of frequently prescribed pharmaceuticals in Slovakia.

Authors:  Tomáš Mackuľak; Lucia Birošová; Miroslav Gál; Igor Bodík; Roman Grabic; Jozef Ryba; Jaroslav Škubák
Journal:  Environ Monit Assess       Date:  2015-12-09       Impact factor: 2.513

4.  Pharmaceutical wastewater being composite mixture of environmental pollutants may be associated with mutagenicity and genotoxicity.

Authors:  Ali Sharif; Muhammad Ashraf; Aftab Ahmed Anjum; Aqeel Javeed; Imran Altaf; Muhammad Furqan Akhtar; Mateen Abbas; Bushra Akhtar; Ammara Saleem
Journal:  Environ Sci Pollut Res Int       Date:  2015-10-10       Impact factor: 4.223

5.  Different compositions of pharmaceuticals in Dutch and Belgian rivers explained by consumption patterns and treatment efficiency.

Authors:  Thomas L ter Laak; Pascal J F Kooij; Harry Tolkamp; Jan Hofman
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-29       Impact factor: 4.223

Review 6.  Environmental impacts of the widespread use of chlorine-based disinfectants during the COVID-19 pandemic.

Authors:  Naseeba Parveen; Shamik Chowdhury; Sudha Goel
Journal:  Environ Sci Pollut Res Int       Date:  2022-01-29       Impact factor: 4.223

Review 7.  Transformation Products of Emerging Pollutants Explored Using Non-Target Screening: Perspective in the Transformation Pathway and Toxicity Mechanism-A Review.

Authors:  Thodhal-Yoganandham Suman; Soo-Yeon Kim; Dong-Hyuk Yeom; Junho Jeon
Journal:  Toxics       Date:  2022-01-24

8.  Sex-Specific and Long-Term Impacts of Early-Life Venlafaxine Exposure in Zebrafish.

Authors:  William Andrew Thompson; Zachary Shvartsburd; Mathilakath M Vijayan
Journal:  Biology (Basel)       Date:  2022-02-06

9.  Investigating the removal of some pharmaceutical compounds in hospital wastewater treatment plants operating in Saudi Arabia.

Authors:  Hamed Al Qarni; Philip Collier; Juliette O'Keeffe; Joseph Akunna
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-21       Impact factor: 4.223

10.  Association between Aquatic Micropollutant Dissipation and River Sediment Bacterial Communities.

Authors:  Claudia Coll; Raven Bier; Zhe Li; Silke Langenheder; Elena Gorokhova; Anna Sobek
Journal:  Environ Sci Technol       Date:  2020-10-26       Impact factor: 9.028

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.